TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medibank Private ( (AU:MPL) ) has issued an update.
Medibank Private Limited has announced a change in the director’s interest for David Koczkar, as per the requirements of the Listing Rules. This change involves the adjustment of performance rights under the company’s Performance Rights Plan, reflecting the company’s ongoing commitment to aligning executive incentives with long-term performance goals. This update is part of Medibank’s governance practices and may impact stakeholders by indicating the company’s strategic focus on performance-driven leadership.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.05 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited operates in the health insurance industry, providing a range of health insurance products and services to individuals and families in Australia. The company focuses on delivering health insurance solutions that cater to various customer needs, emphasizing quality healthcare and customer service.
Average Trading Volume: 5,354,018
Technical Sentiment Signal: Buy
Current Market Cap: A$13.99B
For a thorough assessment of MPL stock, go to TipRanks’ Stock Analysis page.